American Heart Association Ventures Invests in MDisrupt

美国心脏协会风险投资公司投资MDisrupt

Lisa Suennen, Managing Partner of American Heart Association Ventures and Longtime Healthcare Veteran, Joins the MDisrupt Board

MDisrupt’s Marketplace will be Made Available to Thousands of the American Heart Association’s Professional Members

MDisrupt的市场将向数千名美国心脏协会的专业成员开放

The American Heart Association and MDisrupt Collaborate to Expand the AI-Powered Health Expert Marketplace

美国心脏协会和MDisrupt合作扩大人工智能驱动的健康专家市场

MDisrupt, the premier expert marketplace for the health tech and life sciences industries, today announced it has received a milestone-based $1 million investment from American Heart Association Ventures, the newly established venture arm that leads and coordinates the Association’s venture capital investments.

MDisrupt是健康技术和生命科学行业的首要专家市场，今天宣布，它收到了美国心脏协会风险投资公司（American Heart Association Ventures）的一笔具有里程碑意义的100万美元投资，这是一家新成立的风险投资机构，负责领导和协调该协会的风险投资。

In addition, the American Heart Association entered into a services agreement with MDisrupt..

此外，美国心脏协会与MDisrupt签订了服务协议。。

The investment will support expanded adoption of MDisrupt’s recently launched Artificial Intelligence (AI)-Powered Health Expert Marketplace. The marketplace is designed to meet the growing demand by small and large companies for fast and reliable access to vetted clinical, commercial, and scientific experts to advise around designing, building, commercializing, and scaling healthcare products and services..

这项投资将支持MDisrupt最近推出的人工智能（AI）驱动的健康专家市场的扩大采用。该市场旨在满足小型和大型公司对快速可靠地获得经过审查的临床、商业和科学专家的需求，以提供有关设计、建造、商业化和规模化医疗保健产品和服务的建议。。

In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device, and life sciences sectors. This collaboration will enable members to advance the Association’s mission of spreading evidence-based, high-quality scientific expertise across the healthcare ecosystem..

此外，MDisrupt将通过与该协会的战略合作，为市场平台增加新功能，以满足其成员的需求，为他们提供与卫生技术、卫生服务、医疗器械和生命科学部门接触的新方式。这种合作将使成员能够推进该协会在整个医疗保健生态系统中传播循证、高质量科学专业知识的使命。。

“Healthcare experts are the catalysts behind scalable, science-based innovation. This strategic investment from American Heart Association Ventures accelerates our mission to provide health care and life sciences companies with unparalleled access to top clinicians and scientists, including those specializing in cardiovascular and brain health,” said Ruby Gadelrab, Founder and CEO at MDisrupt.

MDisrupt创始人兼首席执行官Ruby Gadelrab说：“医疗保健专家是可扩展的、基于科学的创新背后的催化剂。美国心脏协会风险投资公司的这项战略投资加速了我们的使命，为医疗保健和生命科学公司提供无与伦比的机会，让顶级临床医生和科学家，包括那些专门从事心血管和大脑健康的科学家获得服务。”。

“Our collaboration with the Association will create valuable opportunities for thousands of members to engage with industry, apply their expertise in new roles, and shape the future of healthcare technology.”.

“我们与该协会的合作将为数千名会员创造宝贵的机会，让他们参与行业，将专业知识应用于新角色，并塑造医疗保健技术的未来。”。

Healthcare industry veteran Lisa Suennen, Managing Partner at American Heart Association Ventures, also joined MDisrupt’s Board of Directors, bringing decades of leadership experience and a proven track record in health innovation to support MDisrupt’s continued growth.

美国心脏协会风险投资管理合伙人、医疗保健行业资深人士丽莎·苏恩（LisaSuennen）也加入了MDisrupt的董事会，为MDisrupt的持续增长带来了数十年的领导经验和健康创新方面的良好记录。

“We are excited about this relationship because it allows us to bring even more value to the American Heart Association members and to further disseminate our members’ impressive knowledge to advance solutions that are scientifically validated, evidence-based, and essential for the healthcare industry,” Suennen said.

Suennen说：“我们对这种关系感到兴奋，因为它使我们能够为美国心脏协会成员带来更多价值，并进一步传播我们成员令人印象深刻的知识，以推进科学验证、循证且对医疗行业至关重要的解决方案。”。

“We are thrilled to make this strategic investment in MDisrupt and to have this opportunity to support our members and the healthcare and life sciences marketplace by matching needs with expertise in a way that benefits all. Through this collaboration, MDisrupt will help give Association members a unique opportunity to shape the next generation of healthcare solutions.”.

“我们很高兴能对MDisrupt进行这项战略投资，并有机会通过将需求与专业知识相匹配，以造福所有人的方式支持我们的成员以及医疗保健和生命科学市场。通过这次合作，MDisrupt将有助于为协会成员提供一个独特的机会，以塑造下一代医疗保健解决方案。”。

American Heart Association Ventures is an investment platform that leads and coordinates the venture capital programs of the Association, building upon the overall mission by funding programs that ensure the translation of high-quality, evidence-based science, research, and clinical know-how into an actionable, meaningful, equitable, and sustainable positive impact for patients and the health care system..

美国心脏协会风险投资公司是一个投资平台，领导和协调协会的风险投资项目，通过资助项目，确保将高质量、循证科学、研究和临床专有技术转化为对患者和医疗保健系统具有可操作、有意义、公平和可持续的积极影响，从而实现协会的整体使命。。

Suennen added, “The collaboration with MDisrupt will help us deliver on our mission to be a relentless force for a world of longer, healthier lives. Building on more than 100 years of trusted leadership in cardiovascular and brain health, the American Heart Association is focused on driving breakthroughs and helping advance proven solutions that advance health and hope for everyone, everywhere.”.

Suennen补充道：“与MDisrupt的合作将帮助我们实现我们的使命，成为一支无情的力量，创造一个拥有更长、更健康生命的世界。美国心脏协会在心血管和大脑健康领域拥有100多年值得信赖的领导力，在此基础上，致力于推动突破，并帮助推进经验证的解决方案，从而促进每个人、每个地方的健康和希望。”。

Healthcare Experts – the Critical Factor for Success in New Healthcare Products and Services

While health tech, tech-enabled services, medical devices, and life sciences are abundant with innovation, the path to success is challenging. For instance, in the United States, 75 percent of medical device start-ups fail, and 98 percent of digital health startups don’t survive. The landscape for connected devices and apps is similarly daunting, with an astonishing 350,000 health apps available and more than 90,000 released in 2020 alone – yet about 53 percent are uninstalled within 30 days. Early-stage healthcare companies frequently falter because they lack clinical, regulatory, and commercialization expertise; they also face significant post-market hurdles such as recalls, reimbursement challenges, or poor market performance..

虽然卫生技术、科技服务、医疗设备和生命科学都有丰富的创新，但通往成功的道路是具有挑战性的。例如，在美国，75%的医疗设备初创公司失败，98%的数字健康初创公司无法生存。互联设备和应用程序的前景同样令人望而生畏，仅2020年就有35万个健康应用程序可用，超过9万个应用程序发布，但约53%的应用程序在30天内卸载。早期医疗保健公司经常动摇，因为他们缺乏临床，监管和商业化专业知识；他们还面临着重大的上市后障碍，如召回、报销挑战或市场表现不佳。。

“Too many promising companies struggle not due to a lack of innovation but because they can’t access deeply specialized healthcare expertise when it’s needed most. Whether it’s navigating complex regulations, generating evidence, commercialization, or engaging with payers and health systems, the nuanced, healthcare-specific guidance we provide through MDisrupt is critical.

“太多有前途的公司苦苦挣扎，不是因为缺乏创新，而是因为他们无法在最需要的时候获得深度专业化的医疗保健专业知识。无论是在复杂的法规中航行，产生证据，商业化，还是与付款人和卫生系统打交道，我们通过MDisrupt提供的针对医疗保健的细微指导都至关重要。

Unlike general expert platforms, we focus exclusively on every aspect of health care, offering vetted, curated experts who can accelerate a company’s path to market. Our marketplace delivers the right expertise at the right time, empowering companies to move faster and more responsibly,” said Gadelrab..

与一般的专家平台不同，我们专注于医疗保健的各个方面，提供经过审查和策划的专家，他们可以加速公司进入市场的步伐。我们的市场在正确的时间提供正确的专业知识，使公司能够更快、更负责任地行动，”Gadelrab说。。

The MDisrupt marketplace currently provides access to more than 2,500 vetted experts who worked at established healthcare enterprises, such as Blue Cross Blue Shield, Walgreens, CVS, Willis Towers Watson, U.S. FDA, Optum, Humana, Kaiser, Cleveland Clinic, and more.

MDisrupt marketplace目前提供2500多名经过审查的专家，这些专家曾在已建立的医疗保健企业工作，如蓝十字蓝盾、沃尔格林、CVS、威利斯·托尔斯·沃森、美国FDA、Optum、Humana、Kaiser、克利夫兰诊所等。

MDisrupt’s AI-Powered Health Expert Marketplace connects health tech and life sciences companies, as well as venture and private equity funds, with vetted experts whose skills are highly specific and nuanced to meet healthcare’s unique challenges. The platform’s precision matching ensures that companies find the exact experts they need, whether for clinical, commercial, regulatory, or reimbursement expertise.

MDisrupt的人工智能健康专家市场将健康技术和生命科学公司以及风险投资和私人股本基金与经过审查的专家联系起来，这些专家的技能非常具体，可以应对医疗保健的独特挑战。该平台的精确匹配可确保公司找到他们所需的确切专家，无论是临床、商业、监管还是报销专业知识。

Companies can engage these experts in various ways, from hourly consultations and advisory boards to fractional, part-time, or full-time roles, ensuring flexibility and tailored expertise for every stage of their growth..

公司可以通过各种方式聘请这些专家，从每小时咨询和咨询委员会到兼职、兼职或全职角色，确保其成长的每个阶段都具有灵活性和量身定制的专业知识。。

MDisrupt was founded by Gadelrab, a seasoned health tech executive who has successfully commercialized healthcare and life sciences, served on the executive team at 23andMe, and advised many leading companies in the biotech and genetics sectors. MDisrupt has raised $6.6 million to date, including its most recent $3 million in seed funding.

MDisrupt由Gadelrab创立，Gadelrab是一位经验丰富的健康技术高管，他成功地将医疗保健和生命科学商业化，曾在23andMe的高管团队中任职，并为生物技术和遗传学领域的许多领先公司提供咨询。MDisrupt迄今已筹集660万美元，其中包括最近的300万美元种子资金。

Notable investors include The Venture Collective, Capita3, The Good Science Fund, Zane Venture Fund, Growth Factory, Susan Solinsky, Matthew Holt, and other strategic investors and industry leaders in the healthcare and technology sectors..

著名的投资者包括风险投资集团、Capital3、良好科学基金、Zane风险基金、Growth Factory、Susan Solinsky、Matthew Holt以及医疗保健和技术领域的其他战略投资者和行业领袖。。

About MDisrupt

关于MDisrupt

MDisrupt is the premier expert marketplace for the health tech and life sciences industry, connecting companies with over 2,500 top-tier professionals, including clinicians, health system executives, and payor leaders. The company’s AI-powered platform streamlines access to essential expertise, enabling rapid product development and validation.

MDisrupt是卫生技术和生命科学行业的首要专家市场，将拥有2500多名顶级专业人员（包括临床医生、卫生系统高管和付款人领导者）的公司联系起来。该公司的人工智能平台简化了对基本专业知识的访问，实现了快速的产品开发和验证。

By uniting the best minds in healthcare, MDisrupt ensures that health innovations are built on a foundation of clinical rigor and are ready for market success acceleration. For more information, visit mdisrupt.com, and follow on LinkedIn..

通过团结医疗保健领域的精英，MDisrupt确保医疗创新建立在严格的临床基础上，并为加速市场成功做好准备。有关更多信息，请访问mdisrupt.com，并关注LinkedIn。。

Originally announced October 15th, 2024

最初于2024年10月15日宣布

Tags23andMe American Heart Association Ventures Capita3 Growth Factory Health IT Funding Health IT Fundings Health IT Investment Lisa Suennen Matthew Holt MDisrupt Ruby Gadelrab Susan Solinsky The Good Science Fund The Venture Collective Zane Venture Fund

Tags23和Me美国心脏协会风险投资资本3成长工厂健康IT资金健康IT资金健康IT资金健康IT投资丽莎·苏恩·马修·霍尔特·姆迪斯鲁普·鲁比·加德拉布·苏珊·索林斯基良好科学基金风险投资集体赞恩风险基金

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息